| L‐asparaginase treatment in acute lymphoblastic leukemia A focus on Erwinia asparaginase R Pieters, SP Hunger, J Boos, C Rizzari, L Silverman, A Baruchel, ... Cancer 117 (2), 238-249, 2011 | 658 | 2011 |
| Phase I/phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia A von Stackelberg, F Locatelli, G Zugmaier, R Handgretinger, TM Trippett, ... Journal of Clinical Oncology 34 (36), 4381-4389, 2016 | 573 | 2016 |
| Emapalumab in children with primary hemophagocytic lymphohistiocytosis F Locatelli, MB Jordan, C Allen, S Cesaro, C Rizzari, A Rao, B Degar, ... New England Journal of Medicine 382 (19), 1811-1822, 2020 | 381 | 2020 |
| Collaborative efforts driving progress in pediatric acute myeloid leukemia CM Zwaan, EA Kolb, D Reinhardt, J Abrahamsson, S Adachi, R Aplenc, ... Journal of clinical oncology 33 (27), 2949, 2015 | 375 | 2015 |
| Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group GJL Kaspers, M Zimmermann, D Reinhardt, BES Gibson, RYJ Tamminga, ... Journal of Clinical Oncology 31 (5), 599-607, 2013 | 256 | 2013 |
| Ancestry and pharmacogenetics of antileukemic drug toxicity S Kishi, C Cheng, D French, D Pei, S Das, EH Cook, N Hijiya, C Rizzari, ... Blood 109 (10), 4151-4157, 2007 | 248 | 2007 |
| Long-Term Results of a Randomized Trial on Extended Use of High Dose l-Asparaginase for Standard Risk Childhood Acute Lymphoblastic Leukemia A Pession, MG Valsecchi, G Masera, WA Kamps, E Magyarosy, C Rizzari, ... Journal of clinical oncology 23 (28), 7161-7167, 2005 | 222 | 2005 |
| Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment O Hrusak, T Kalina, J Wolf, A Balduzzi, M Provenzi, C Rizzari, S Rives, ... European Journal of Cancer 132, 11-16, 2020 | 219 | 2020 |
| Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial F Locatelli, G Zugmaier, C Rizzari, JD Morris, B Gruhn, T Klingebiel, ... Jama 325 (9), 843-854, 2021 | 217 | 2021 |
| Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia A Pession, R Masetti, C Rizzari, MC Putti, F Casale, F Fagioli, M Luciani, ... Blood, The Journal of the American Society of Hematology 122 (2), 170-178, 2013 | 217 | 2013 |
| Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation IM van der Sluis, LM Vrooman, R Pieters, A Baruchel, G Escherich, ... Haematologica 101 (3), 279, 2016 | 215 | 2016 |
| Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia V Conter, M Aricò, G Basso, A Biondi, E Barisone, C Messina, R Parasole, ... Leukemia 24 (2), 255-264, 2010 | 214 | 2010 |
| Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia … A Balduzzi, E Brivio, A Rovelli, C Rizzari, S Gasperini, ML Melzi, V Conter, ... Bone Marrow Transplantation 55 (10), 1900-1905, 2020 | 171 | 2020 |
| Asparaginase pharmacokinetics and implications of therapeutic drug monitoring B Asselin, C Rizzari Leukemia & lymphoma 56 (8), 2273-2280, 2015 | 164 | 2015 |
| Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982–1995 V Conter, M Arico, MG Valsecchi, G Basso, A Biondi, E Madon, F Mandelli, ... Leukemia 14 (12), 2196-2204, 2000 | 163 | 2000 |
| A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia C Rizzari, M Citterio, M Zucchetti, V Conter, R Chiesa, A Colombini, ... haematologica 91 (1), 24-31, 2006 | 146 | 2006 |
| Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with … V Conter, M Arico, MG Valsecchi, C Rizzari, AM Testi, C Messina, PG Mori, ... Journal of clinical oncology 13 (10), 2497-2502, 1995 | 132 | 1995 |
| Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II M Arico, MG Valsecchi, V Conter, C Rizzari, A Pession, C Messina, ... Blood, The Journal of the American Society of Hematology 100 (2), 420-426, 2002 | 129 | 2002 |
| L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving im or iv Erwinia C. or E. coli L-asparaginase as first exposure C Rizzari, M Zucchetti, V Conter, L Diomede, A Bruno, L Gavazzi, ... Annals of oncology 11 (2), 189-193, 2000 | 127 | 2000 |
| Children with cancer in the time of COVID‐19: an 8‐week report from the six pediatric onco‐hematology centers in Lombardia, Italy A Ferrari, M Zecca, C Rizzari, F Porta, M Provenzi, M Marinoni, ... Pediatric blood & cancer 67 (8), 2020 | 122 | 2020 |
